CDH1 and breast carcinoma: Metastatic cells use E-cadherin in metastatic sites to detach, disseminate, and seed.180 This promotes metastatic cell survival and blocks reactive oxygen-mediated apoptosis.180 As such, inhibiting E-cadherin in metastatic breast cancer cells may hold therapeutic potential against breast cancer.180